PHILIPS NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.84 EUR | -0.80% |
|
+25.80% | +17.81% |
| May. 03 | Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio | MT |
| May. 02 | PHILIPS NV : DZ Bank reiterates its Neutral rating | ZD |
Presentation Operator MessageOperator (Operator)Welcome to the Royal Philips Third Quarter 202...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
08:00am
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
24.84
EUR
Average target price
24.43
EUR
Spread / Average Target
-1.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.81% | 24.39B | |
| +8.06% | 218B | |
| +6.94% | 184B | |
| +13.54% | 135B | |
| -0.27% | 62.38B | |
| +11.59% | 51.37B | |
| +7.76% | 50.9B | |
| +1.14% | 40.87B | |
| +3.21% | 36.28B | |
| +26.11% | 31.88B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Transcript : Koninklijke Philips N.V., Q3 2023 Earnings Call, Oct 23, 2023